Tune Therapeutics Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases

DURHAM, N.C. and SEATTLE, Dec. 2, 2021 /PRNewswire/ -- Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched today with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology dials gene expression up or...

from PR Newswire: https://ift.tt/3xNEjZm